Slow Q1 For Baxter, But Board Remains Confident Of Turnaround

Baxter International recorded slight revenue increases during quarter one of 2021, with sales still impacted by COVID-19. Its board remains optimistic , pointing towards new product releases and “operational strength” as redeeming factors.

Earning Report Q1

More from Surgery

More from Device Area